What Happened
Palm Care Pharmacy, a San Diego County pharmacy chain operated by Talimi International, Inc., paid $350,000 in a settlement announced on May 2, 2024, to resolve allegations about its El Cajon location. Based on a DEA inventory audit, the government alleged that from 2018 through 2022 the pharmacy failed to control its controlled substance inventory, failed to keep complete records of controlled substances, and sold pseudoephedrine products without required training and certification. The failures left unaccounted-for pills, including oxycodone, hydrocodone, tramadol, Xanax and Soma. The pharmacy also entered a Memorandum of Agreement with the DEA. Liability was not determined.
“has paid $350,000 to resolve allegations that it diverted controlled substances, failed to keep necessary accounting records for controlled substances”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.